Isomorphic Labs in Talks to Raise $2B+ at $40-50B Valuation, Alphabet Drug-Discovery Spinout

Isomorphic Labs, the AI-powered drug-discovery company spun out of Google DeepMind, is in early talks to raise more than $2 billion at a valuation of at least $40 billion and potentially up to $50 billion, per Bloomberg sources. The round, which has not closed, would mark a steep step up from its $2.1 billion Series B earlier in 2026 and extend Alphabet's push to monetize AlphaFold-era research.